Details for New Drug Application (NDA): 202112
✉ Email this page to a colleague
The generic ingredient in GLIMEPIRIDE is glimepiride. There are sixteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the glimepiride profile page.
Summary for 202112
Tradename: | GLIMEPIRIDE |
Applicant: | Indoco Remedies |
Ingredient: | glimepiride |
Patents: | 0 |
Suppliers and Packaging for NDA: 202112
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GLIMEPIRIDE | glimepiride | TABLET;ORAL | 202112 | ANDA | A-S Medication Solutions | 50090-3172 | 50090-3172-0 | 30 TABLET in 1 BOTTLE (50090-3172-0) |
GLIMEPIRIDE | glimepiride | TABLET;ORAL | 202112 | ANDA | A-S Medication Solutions | 50090-3172 | 50090-3172-1 | 100 TABLET in 1 BOTTLE, PLASTIC (50090-3172-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
Approval Date: | Apr 17, 2013 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
Approval Date: | Apr 17, 2013 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 4MG | ||||
Approval Date: | Apr 17, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription